Revenue rose 4.7%, but Ryan Specialty's organic growth slowed to 4% from 15%
Ryan Specialty reported Q3 2026 revenue growth of 4.7% YoY to $789.96M, with organic growth slowing to 4% from 15%. Net income rose 40.6% to $88.05M, while adjusted EBITDAC increased 3.8% to $244.45M. The company returned $173.7M to shareholders through stock repurchases and dividends. Management cited challenging market conditions but expressed confidence in long-term value creation. (Character count: 349)
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data on revenue, profitability, and shareholder returns, informing short-term trading decisions.
Market read
First-report earnings data for a mid-cap insurer, offering actionable insight for traders.
What to watch
Management’s investment in AI and data may drive longer-term margin expansion.
Background
Ryan Specialty Holdings, a specialty insurance provider, reported Q3 2026 results with modest revenue growth and increased cash returns to shareholders.
Market effects
Specialty insurance sector may see mixed reactions as growth slowdown signals broader market pressure.
U.S. insurers could experience slight valuation adjustments.
Limited, confined to specialty insurance niche.
Counterpoint
Despite slower organic growth, the company’s strong cash returns and dividend could support the stock.
Key entities
- CompanyRyan Specialty Holdings, Inc.
Issuer of the earnings report.
- ExecutivePatrick G. Ryan
Founder and Executive Chairman, quoted in the release.

